Aurinia Pharmaceuticals Inc (AUPH)

[moosedogger]

It's interesting how Kezar makes these results sound positive in their PR:

"“Presenting our first in patient data with KZR-616, our novel selective immunoproteasome inhibitor, is an important milestone for Kezar and represents the culmination of several years of our team’s research and development efforts,” said Niti Goel, MD, FACR, Kezar’s Chief Medical Officer. “We are encouraged by the safety, tolerability, and potential efficacy seen thus far in the MISSION trial and look forward to sharing the detailed results with the clinical and scientific community next month. The Phase 2 portion in lupus nephritis patients has commenced enrollment, and we have identified 30 and 45mg as the appropriate doses to advance in each of our Phase 2 autoimmune clinical trials. We expect to initiate trials with KZR-616 in dermatomyositis, polymyositis, autoimmune hemolytic anemia, and immune thrombocytopenia later this year.”"

http://investors.kezarlifesciences.com/news-releases/news-release-details/kezar-life-sciences-announces-acceptance-abstract-presentation

Wonder if Celia misses Aurinia?